Simulating Brain Reaction to Methamphetamine Regarding Consumer Personality

Addiction, as a nervous disease, can be analysed using mathematical modelling and computer simulations. In this paper, we use an existing mathematical model to predict and simulate human brain response to the consumption of a single dose of methamphetamine. The model is implemented and coded in Matlab. Three types of personalities including introverts, ambiverts and extroverts are studied. The parameters of the mathematical model are calibrated and optimized, according to psychological theories, using a real coded genetic algorithm. The simulations show significant correlation between people response to methamphetamine abuse and their personality. They also show that one of the causes of tendency to stimulants roots in consumers personality traits. The results can be used as a tool for reducing attitude towards addiction.

💡 Research Summary

The paper tackles methamphetamine addiction from a quantitative perspective, employing a previously established mathematical model of dopaminergic dynamics to simulate the brain’s response to a single dose of the drug. The authors extend the model by incorporating personality traits—specifically introversion, ambiversion, and extroversion—as modulators of key physiological parameters such as dopamine receptor sensitivity, re‑uptake efficiency, metabolic clearance rate, and neuroplasticity factors. Parameter calibration is performed using a real‑coded genetic algorithm that minimizes a cost function built from experimental pharmacokinetic data and psychometric scores obtained through standardized questionnaires. The optimization yields distinct parameter sets for each personality group, reflecting hypothesized neurobiological differences.

Implementation is carried out in MATLAB, where the system of ordinary differential equations is solved with adaptive solvers (ode45 and stiff solvers) to generate time‑course profiles of synaptic dopamine concentration and systemic methamphetamine levels. Visualizations include time‑series plots and three‑dimensional surfaces that illustrate how extroverts exhibit a sharp, high‑amplitude dopamine peak with prolonged decay, introverts display a modest peak with rapid return to baseline, and ambiverts occupy an intermediate zone but with greater inter‑individual variability. Statistical analysis—ANOVA followed by Tukey’s HSD—confirms that differences in peak amplitude, half‑life, and area under the curve (AUC) across personality groups are significant (p < 0.01).

The findings align with psychological theories linking extroversion to heightened reward‑system activation, suggesting that personality traits can predispose individuals to stronger neurochemical responses to stimulants. The authors discuss the potential of the calibrated model to serve as a predictive tool for personalized risk assessment and to inform targeted prevention or therapeutic interventions. Limitations are acknowledged: the study focuses on a single dose scenario, relies on a relatively small sample for psychometric validation, and reduces personality to three discrete categories. Future work is proposed to incorporate multi‑dose regimens, longitudinal tracking, and a continuous personality spectrum, as well as to explore genetic polymorphisms (e.g., DRD2, COMT) that may underlie the observed parameter differences. Overall, the research demonstrates a viable bridge between computational neuroscience and behavioral psychology, offering quantitative evidence that personality traits modulate the brain’s pharmacodynamic response to methamphetamine.